Literature DB >> 33423291

IRF5 regulates airway macrophage metabolic responses.

G J Albers1, J Iwasaki1, P McErlean1, P P Ogger1, P Ghai1, T E Khoyratty2, I A Udalova2, C M Lloyd1, A J Byrne1.   

Abstract

Interferon regulatory factor 5 (IRF5) is a master regulator of macrophage phenotype and a key transcription factor involved in expression of proinflammatory cytokine responses to microbial and viral infection. Here, we show that IRF5 controls cellular and metabolic responses. By integrating ChIP sequencing (ChIP-Seq) and assay for transposase-accessible chromatin using sequencing (ATAC)-seq data sets, we found that IRF5 directly regulates metabolic genes such as hexokinase-2 (Hk2). The interaction of IRF5 and metabolic genes had a functional consequence, as Irf5-/- airway macrophages but not bone marrow-derived macrophages (BMDMs) were characterized by a quiescent metabolic phenotype at baseline and had reduced ability to utilize oxidative phosphorylation after Toll-like receptor (TLR)-3 activation, in comparison to controls, ex vivo. In a murine model of influenza infection, IRF5 deficiency had no effect on viral load in comparison to wild-type controls but controlled metabolic responses to viral infection, as IRF5 deficiency led to reduced expression of Sirt6 and Hk2. Together, our data indicate that IRF5 is a key component of AM metabolic responses following influenza infection and TLR-3 activation.
© 2021 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology.

Entities:  

Keywords:  lung; macrophage; metabolism; transcription factors; virus

Mesh:

Substances:

Year:  2021        PMID: 33423291      PMCID: PMC7944363          DOI: 10.1111/cei.13573

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  24 in total

Review 1.  A guide to immunometabolism for immunologists.

Authors:  Luke A J O'Neill; Rigel J Kishton; Jeff Rathmell
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

2.  Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages.

Authors:  Christoph Schneider; Samuel P Nobs; Michael Kurrer; Hubert Rehrauer; Christoph Thiele; Manfred Kopf
Journal:  Nat Immunol       Date:  2014-09-28       Impact factor: 25.606

3.  IRF5 controls both acute and chronic inflammation.

Authors:  Miriam Weiss; Adam J Byrne; Katrina Blazek; David G Saliba; James E Pease; Dany Perocheau; Marc Feldmann; Irina A Udalova
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

4.  In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing.

Authors:  Gabriel Courties; Timo Heidt; Matthew Sebas; Yoshiko Iwamoto; Derrick Jeon; Jessica Truelove; Benoit Tricot; Greg Wojtkiewicz; Partha Dutta; Hendrik B Sager; Anna Borodovsky; Tatiana Novobrantseva; Boris Klebanov; Kevin Fitzgerald; Daniel G Anderson; Peter Libby; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Am Coll Cardiol       Date:  2013-12-18       Impact factor: 24.094

5.  The cis-Regulatory Atlas of the Mouse Immune System.

Authors:  Hideyuki Yoshida; Caleb A Lareau; Ricardo N Ramirez; Samuel A Rose; Barbara Maier; Aleksandra Wroblewska; Fiona Desland; Aleksey Chudnovskiy; Arthur Mortha; Claudia Dominguez; Julie Tellier; Edy Kim; Dan Dwyer; Susan Shinton; Tsukasa Nabekura; YiLin Qi; Bingfei Yu; Michelle Robinette; Ki-Wook Kim; Amy Wagers; Andrew Rhoads; Stephen L Nutt; Brian D Brown; Sara Mostafavi; Jason D Buenrostro; Christophe Benoist
Journal:  Cell       Date:  2019-01-24       Impact factor: 41.582

6.  The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation.

Authors:  Freya R Svedberg; Sheila L Brown; Maria Z Krauss; Laura Campbell; Catherine Sharpe; Maryam Clausen; Gareth J Howell; Howard Clark; Jens Madsen; Christopher M Evans; Tara E Sutherland; Alasdair C Ivens; David J Thornton; Richard K Grencis; Tracy Hussell; Danen M Cunoosamy; Peter C Cook; Andrew S MacDonald
Journal:  Nat Immunol       Date:  2019-04-01       Impact factor: 31.250

7.  IRF5:RelA interaction targets inflammatory genes in macrophages.

Authors:  David G Saliba; Andreas Heger; Hayley L Eames; Spyros Oikonomopoulos; Ana Teixeira; Katrina Blazek; Ariadne Androulidaki; Daniel Wong; Fui G Goh; Miriam Weiss; Adam Byrne; Manolis Pasparakis; Jiannis Ragoussis; Irina A Udalova
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

8.  A critical role for IRF5 in regulating allergic airway inflammation.

Authors:  A J Byrne; M Weiss; S A Mathie; S A Walker; H L Eames; D Saliba; C M Lloyd; I A Udalova
Journal:  Mucosal Immunol       Date:  2016-10-19       Impact factor: 7.313

9.  CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs.

Authors:  M Duan; D P Steinfort; D Smallwood; M Hew; W Chen; M Ernst; L B Irving; G P Anderson; M L Hibbs
Journal:  Mucosal Immunol       Date:  2015-09-30       Impact factor: 7.313

10.  Dynamics of human monocytes and airway macrophages during healthy aging and after transplant.

Authors:  Adam J Byrne; Joseph E Powell; Brendan J O'Sullivan; Patricia P Ogger; Ashley Hoffland; James Cook; Katie L Bonner; Richard J Hewitt; Simone Wolf; Poonam Ghai; Simone A Walker; Samuel W Lukowski; Philip L Molyneaux; Sejal Saglani; Daniel C Chambers; Toby M Maher; Clare M Lloyd
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

View more
  2 in total

Review 1.  The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity.

Authors:  Calum C Bain; Andrew S MacDonald
Journal:  Mucosal Immunol       Date:  2022-01-11       Impact factor: 7.313

2.  Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling.

Authors:  L Orliaguet; T Ejlalmanesh; A Humbert; R Ballaire; M Diedisheim; J B Julla; D Chokr; J Cuenco; J Michieletto; J Charbit; D Lindén; J Boucher; C Potier; A Hamimi; S Lemoine; C Blugeon; P Legoix; S Lameiras; L G Baudrin; S Baulande; A Soprani; F A Castelli; F Fenaille; J P Riveline; E Dalmas; J Rieusset; J F Gautier; N Venteclef; F Alzaid
Journal:  Nat Commun       Date:  2022-08-30       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.